Fig. 1From: Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trialFlow diagram of ARNEO. Ga: Gallium. bGS: biopsy Gleason score. MR: magnetic resonance. PCa: prostate cancer. PET: Positron Emission Tomography. PLND: pelvic lymph node dissection. PSMA: prostate specific membrane antigen. RP: radical prostatectomyBack to article page